Hoffman A L, Makowka L, Cramer D V, Cai X, Pascualone A, Banner B F, Sheahan D G, Rettinger P, Starzl T E
Department of Surgery, University of Pittsburgh School of Medicine, PA 15261.
J Invest Surg. 1989;2(3):241-51. doi: 10.3109/08941938909057430.
Graft versus host disease (GVHD) may be abrogated and host survival prolonged by in vitro depletion of T lymphocytes from bone marrow (BM) prior to allotransplantation. Using a mouse anti-rat pan T-lymphocyte monoclonal antibody (OX19) bound to monosized, magnetic, polymer beads, T lymphocytes were removed in vitro from normal bone marrow. The removal of the T lymphocytes was confirmed by flow cytometry. Injection of the T-lymphocyte-depleted bone marrow into fully allogeneic rats prevents the induction of GVHD and prolongs host survival.
移植物抗宿主病(GVHD)可通过在同种异体移植前体外去除骨髓(BM)中的T淋巴细胞来消除,并延长宿主存活时间。使用与单尺寸磁性聚合物珠结合的小鼠抗大鼠全T淋巴细胞单克隆抗体(OX19),在体外从正常骨髓中去除T淋巴细胞。通过流式细胞术确认T淋巴细胞的去除。将去除T淋巴细胞的骨髓注射到完全同种异体的大鼠中可防止GVHD的诱导并延长宿主存活时间。